 |
||||||
 |
|
|
|
|
|
|
 |
|||||
 |
|
||||
 |
|||||
 |
|
 |
|||
 |
|||||
|
|||||
Investment Highlights
- Leading brand name in blood processing
- Global market share leader
- Reputation for innovation
- Cash generating business model
- Sustained operating leverage
Financial Highlights*
| $ in millions, except share date | 2009 | 2008 | 2007 | 2006 | 2005 | |
|---|---|---|---|---|---|---|
| Net revenues | $598 | $516 | $450 | $420 | $384 | |
| Gross profit | 308 | 258 | 228 | 221 | 198 | |
| R&D expenses | 24 | 24 | 24 | 27 | 20 | |
| Total operating expenses | 216 | 181 | 158 | 148 | 138 | |
| Operating income | 93 | 77 | 70 | 73 | 60 | |
| Net income | $64 | $56 | $53 | $52 | $40 | |
| Net income per share (diluted) | $2.45 | $2.10 | $1.90 | $1.90 | $1.52 | |
| Cash flow from operations | $47 | $78 | $84 | $86 | $71 | |
| Cash and short-term investments | 157 | 134 | 229 | 251 | 186 | |
| Debt | 6 | 12 | 29 | 39 | 46 | |
*Adjusted to exclude certain benefits and expenses. Results are reconciled to US GAAP under Non-GAAP financials.
Strategy Highlights
- Leverage core business for greater profitability
- Expand business by leveraging core competencies
Sign up for e-mail notifications
|
Products and Services · News · Events · Careers · Investors · Media · Companies · Contact Us · Privacy Statement · Terms of Use · Site Map · Supplier T&C © 2009, Haemonetics Corp., 400 Wood Rd., Braintree, MA, 02184, USA Tel: (800) 225-5242 || Website Design by Garfield Group |
